SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-13-001129
Filing Date
2013-03-15
Accepted
2013-03-15 15:17:12
Documents
5
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2012a1_tianyin.htm 10-K/A 232976
2 CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SA f10k2012a1ex31i_tianyin.htm EX-31.1 17207
3 CERTIFICATIONS OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SAR f10k2012a1ex31ii_tianyin.htm EX-31.2 15910
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, f10k2012a1ex32i_tianyin.htm EX-32.1 8717
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, f10k2012a1ex32ii_tianyin.htm EX-32.2 8024
  Complete submission text file 0001213900-13-001129.txt   284048
Mailing Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041
Business Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041 0086-028-86154737
TIANYIN PHARMACEUTICAL CO., INC. (Filer) CIK: 0001362718 (see all company filings)

IRS No.: 204857782 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-34189 | Film No.: 13693798
SIC: 2834 Pharmaceutical Preparations